ELAB — PMGC Holdings Inc.

—
Nasdaq · Health Care · Pharmaceuticals · CIK 1840563 ·
Last close
$1.27
Market Cap
$1.03M
52W High
$1344.00
52W Low
$1.24
ADV30
532,130
Next earnings
—
PMGC Holdings Inc., doing business as NorthStrive Holdings, Inc, a biopharmaceutical company, focuses on the development and acquisition of aesthetic medicines and therapeutic products. It operates through three segments: corporate, treasury and biosciences; IT packaging solutions; and precision engineering and machining. The company's lead product includes EL-22, a first-in-class engineered probiotic approach to address obesity's pressing issue of preserving muscle while on weight loss treatments, including GLP-1 receptor agonists. It is also involved in the medical scientific research and development activities, as well as operating investment firms; providing packaging solutions to industrial and consumer markets; and design and production of high-tolerance components for industrial and technological applications. The company was formerly known as Elevai Labs, Inc. and changed its name to PMGC Holdings Inc. in December 2024. PMGC Holdings Inc. was incorporated in 2020 and is based in Newport Beach, California.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Jun 2026 1,306,610 385,691 -3,818,179 -2,941,382 36,564,496 18,141,758 19,827,597
Mar 2026 681,994 230,474 -3,320,057 -4,967,259 26,033,318 14,354,374 13,426,865
Dec 2025 304,136 107,284 -2,410,864 -2,982,683 12,868,473 5,402,333 5,031,111
Sep 2025 285,948 78,030 -2,194,727 -2,594,320 14,938,018 7,700,562 6,447,363

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-8,207,541
Investing CF
$-8,915,215
Financing CF
$29,578,970
CapEx
$-805,342
Dividends Paid
—
Buybacks
$0
EPS Diluted TTM
$-1675.75
As of
2026-11-15

Balance + Analyst (yfinance extras)

Retained Earnings
$-28,926,081
Inventory
$932,508
Receivables
$603,487
ST Investments
$650,598
EBIT TTM
$-12,231,634
Pretax Income TTM
$-13,535,199
Interest Exp TTM
$1,303,565
Analysts
—

Yahoo Snapshot (yfinance, live)

Total Revenue
$2,578,688
EBITDA
$-11,544,472
Free Cash Flow
$-4,133,820
Enterprise Value
$-3,445,799
Total Cash
$18,963,356
Total Debt
$14,237,784
Shares Out
809,579
Trailing EPS
$-1748.36
Book Value
$97.11
ROE
-105.2%
ROA
-33.0%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 590,084 -6,821,330 -7,747,813 12,900,000 5,030,000 7,837,362 -5,933,881
Dec 2024 0 -3,657,720 -6,245,737 8,990,000 2,330,000 6,659,564 -5,486,980
Dec 2023 0 -1,134,828 -4,301,517 5,190,000 1,362,842 3,827,076 -4,556,811
Dec 2022 766,277 -1,788,292 -1,800,268 1,890,000 760,873 1,131,310 -1,585,876

TTM Snapshot

Revenues TTM
$2,513,305
NetIncome TTM
$-13,485,644
OpCashFlow TTM
—
Assets (Latest)
$36,564,496
Forward EPS
—

Peers — same industry

TickerNameMarket CapLastDaily %
GOVX GeoVax Labs, Inc. $1.04M $1.91 —
ATXI AVENUE THERAPEUTICS, INC. $988.5K $0.30 —
SKVI SKINVISIBLE, INC. $972.7K $0.18 —
BIOM BIOMOLECULAR LIFE HOLDINGS, INC. $1.15M $0.99 —
ISCO International Stem Cell CORP $1.28M $0.16 —

News headlines (Yahoo Finance, 1h cache)

NorthStrive Defense Tech Announces Successful Completion of Technical Validation and Update to Acquire GPS-Denied Drone Navigation Technology
2026-11-19 15:57 · Yahoo
PMGC Holdings Inc. [NASDAQ: ELAB] Announces Successful Combination of Two Aerospace Manufacturing Companies into a Single California Location, Enhancing Manufacturing and Operational Efficiency and Re
2026-11-17 12:30 · Yahoo
PMGC Holdings Inc. [NASDAQ: ELAB] Reports Record Q3 Revenue, Up 785% Year-over-Year to $2.53 Million and Up 94% From Previous Quarter; Files Form 10-Q for Q3 2026; Total Assets of $133.1 Million Inclu
2026-11-16 12:30 · Yahoo
PMGC Holdings Inc. Announces Strategic Share Acquisition in Australian Space Technology Company Orbit2Orbit
2026-11-10 12:30 · Yahoo
NorthStrive Biosciences Announces Results from EL-32 Preclinical Combination Study with Semaglutide and Plans for Next Phase of Development
2026-11-05 12:31 · Yahoo
PMGC Holdings Inc. Announces DBA as NorthStrive Holdings, Inc., Trademark License Agreement, and Website Update
2026-10-08 14:01 · Yahoo
PMGC Holdings Inc. (Nasdaq: ELAB) Secures Five-Year Royalty Stream from Elevai Skincare Sale Under Executed Payment Agreement with Longevity Health Holdings
2026-09-18 12:00 · Yahoo
NorthStrive Biosciences Expands AI-Driven Drug Discovery Program with Yuva Biosciences, Advancing Four Novel AI-Discovered Compounds Toward Lead Nomination for Potential Cardiac Disease and Obesity Th
2026-09-01 11:45 · Yahoo
PMGC Holdings Terminates Previously Announced Acquisition LOI Following Due Diligence Review; Reaffirms Disciplined M&A Strategy and Expands Investment Across Aerospace & Defense Manufacturing Portfol
2026-08-26 12:17 · Yahoo
PMGC Holdings Signs Orbit2Orbit Term Sheet for Microgravity Muscle Research
2026-08-25 13:46 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.